Blogs

Categories

Select a sub-category to view results

Icon
Films and Coatings
vail 4ml
Pharmaceutical Packaging Components
Icon
Prefillable Systems
Icon
Self Injection Devices
Icon
Vial Containment Solutions
Icon
Washing and Sterilization
Icon
Reconstitution and Transfer Devices

Select a sub-category to view results

Icon
Analytical Lab Services
Icon
Contract Manufacturing
Icon
Fill-Finish
Icon
Regulatory Support

Select a sub-category to view results

Icon
Cell and Gene Therapy Packaging
Icon
Drug Development Process
Icon
Regulatory Challenges
Icon
Transitioning to Combination Products

Select a sub-category to view results

Icon
Corporate Development
Icon
ESG/Sustainability
Icon
One West Team (Employee Culture)
Icon
Our Culture of Giving (Philanthropy)
Icon
Research and Development

Previous Blogs

Mixject

By Daniel Bantz

April 28, 2017

It is imperative for the pharmaceutical industry to be prepared to comply with new compendia chapters as soon as they are enacted.  This comprises knowing of proposed changes as soon as announced, and being well prepared to accommodate them.  Expected to be implemented by late 2018 – the functionality tests section of USP Chapter <381> (Elastomeric Closure for Injections) will be removed, and greatly expanded functionality tests will be incorporated in new USP Chapter <382> (projected title: Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems).